GUAIFENESIN AND PSEUDOEPHEDRINE HCL

GUAIFENESIN AND PSEUDOEPHEDRINE HCL was reported 16 times

GUAIFENESIN AND PSEUDOEPHEDRINE HCL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFUSION SITE STREAKING 1 0.0115
1 PURPURA SENILE 1 0.0082
2 TARSAL TUNNEL SYNDROME 1 0.0045
3 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
4 RESORPTION BONE INCREASED 1 0.0012
5 INFUSION SITE DISCOMFORT 1 0.0010
6 VESTIBULAR DISORDER 1 0.0008
7 INFUSION SITE IRRITATION 1 0.0008
8 INFUSION SITE INDURATION 1 0.0007
9 NASAL ULCER 1 0.0006
10 VERTIGO POSITIONAL 1 0.0006
11 DEVICE ALARM ISSUE 1 0.0006
12 DEVICE INFUSION ISSUE 1 0.0004
13 BLOOD CHLORIDE DECREASED 1 0.0004
14 DEVICE POWER SOURCE ISSUE 1 0.0003
15 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
16 INFUSION SITE ERYTHEMA 2 0.0002
17 PHLEBITIS 1 0.0002
18 INFUSION SITE SWELLING 1 0.0002
19 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
20 OROPHARYNGEAL DISCOMFORT 1 0.0001
21 BLADDER DISORDER 1 0.0001
22 DRY THROAT 1 0.0001
23 TRANSFUSION 1 0.0001
24 VASCULITIS 1 0.0001
25 WRIST FRACTURE 1 0.0001
26 ABNORMAL WEIGHT GAIN 1 0.0001
27 SECRETION DISCHARGE 1 0.0001
28 MYDRIASIS 1 0.0001
29 INFUSION SITE PAIN 1 0.0001
30 DEVICE OCCLUSION 1 0.0001
31 ECONOMIC PROBLEM 1 0.0001
32 OSTEOPENIA 1 0.0001
33 RESPIRATORY TRACT CONGESTION 1 0.0001
34 DEVICE USE ISSUE 1 0.0001
35 GOUT 1 0.0001
36 END STAGE RENAL DISEASE 1 0.0001
37 BLOOD SODIUM DECREASED 1 0.0001
38 GLAUCOMA 1 0.0001
39 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
40 ANHEDONIA 1 0.0000
41 HAEMOPTYSIS 1 0.0000
42 LABORATORY TEST ABNORMAL 1 0.0000
43 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
44 SWELLING FACE 2 0.0000
45 CHOLELITHIASIS 1 0.0000
46 PLASMA CELL MYELOMA 1 0.0000
47 OSTEOPOROSIS 1 0.0000
48 OSTEOARTHRITIS 1 0.0000
49 THROAT IRRITATION 1 0.0000
50 BLOOD CHOLESTEROL INCREASED 1 0.0000
51 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
52 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
53 NASAL CONGESTION 1 0.0000
54 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
55 DEEP VEIN THROMBOSIS 1 0.0000
56 RENAL FAILURE 2 0.0000
57 NEOPLASM MALIGNANT 1 0.0000
58 DEVICE MALFUNCTION 1 0.0000
59 BRONCHITIS 1 0.0000
60 DYSGEUSIA 1 0.0000
61 ARTHRITIS 1 0.0000
62 INFLUENZA LIKE ILLNESS 1 0.0000
63 NEUROPATHY PERIPHERAL 1 0.0000
64 ASTHMA 1 0.0000
65 EMOTIONAL DISTRESS 1 0.0000
66 HYPERHIDROSIS 1 0.0000
67 VISION BLURRED 1 0.0000
68 MEMORY IMPAIRMENT 1 0.0000
69 ACUTE KIDNEY INJURY 1 0.0000
70 PERIPHERAL SWELLING 1 0.0000
71 DRUG INTERACTION 1 0.0000
72 ANAEMIA 1 0.0000
73 ERYTHEMA 1 0.0000
74 DEPRESSION 1 0.0000
75 INCORRECT DOSE ADMINISTERED 1 0.0000
76 WEIGHT DECREASED 1 0.0000
77 DYSPNOEA 2 0.0000
78 ANXIETY 1 0.0000
79 PRODUCT DOSE OMISSION ISSUE 1 0.0000
80 CONDITION AGGRAVATED 1 0.0000
81 MALAISE 1 0.0000
82 VOMITING 1 0.0000
83 DIZZINESS 1 0.0000
84 PAIN 1 0.0000
85 FATIGUE 1 0.0000
86 NAUSEA 1 0.0000
87 DRUG INEFFECTIVE 1 0.0000